Medicine passport

GENVOYA ELVITEGRAVIR 150 mg/COBICISTAT 150 mg/EMTRICITABINA 200 mg/TENOFOVIR ALAFENAMIDA 10 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Elvitegravir + cobicistat + emtricitabina + tenofovir alafenamida
Strength
ELVITEGRAVIR 150 mg/COBICISTAT 150 mg/EMTRICITABINA 200 mg/TENOFOVIR ALAFENAMIDA 10 mg
Form
comprimido recubierto con película
ATC code
J05AR18
Registered in
Spain · Gilead Sciences Ireland Unlimited Company
Prescription
Prescription only
Nº Registro
1151061001IP1

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Canada 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
GENVOYA150 mg + 150 mg + 200 mg + 10 mg · tabletPrescription onlyGilead Sciences Canada Inc02449498

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/es/en/medicines/genvoya-elvitegravir-150-mg-cobicistat-150-mg-emtricitabina-200-mg-tenof-bf7620